CN104017043A - Method for purifying ursodesoxycholic acid by adopting silanization technology - Google Patents

Method for purifying ursodesoxycholic acid by adopting silanization technology Download PDF

Info

Publication number
CN104017043A
CN104017043A CN201410279478.2A CN201410279478A CN104017043A CN 104017043 A CN104017043 A CN 104017043A CN 201410279478 A CN201410279478 A CN 201410279478A CN 104017043 A CN104017043 A CN 104017043A
Authority
CN
China
Prior art keywords
acid
ursodesoxycholic
ursodesoxycholic acid
purifying
silyation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410279478.2A
Other languages
Chinese (zh)
Inventor
曹学君
马小雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East China University of Science and Technology
Original Assignee
East China University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China University of Science and Technology filed Critical East China University of Science and Technology
Priority to CN201711277931.6A priority Critical patent/CN107915767A/en
Priority to CN201410279478.2A priority patent/CN104017043A/en
Publication of CN104017043A publication Critical patent/CN104017043A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention provides a method for purifying ursodesoxycholic acid by adopting a silanization technology. The method is characterized by comprising the following steps: 1, dissolving a mixture containing ursodesoxycholic acid in an organic solvent, adding a silanization reagent at 25-80 DEG C, and reacting to prepare a liquid containing ursodesoxycholic acid silanization derivatives, wherein R is alkyl with 1-5 carbon atoms and X is alkyl with 1-6 carbon atoms; 2, cooling the liquid containing the ursodesoxycholic acid silanization derivatives at 0-5 DEG C, crystallizing and separating to obtain the ursodesoxycholic acid silanization derivatives; and 3, adding the ursodesoxycholic acid silanization derivatives into inorganic acid, stirring, performing acid hydrolysis at 40-60 DEG C, and separating and drying to obtain pure ursodesoxycholic acid. According to the method, the reagent consumption is low, the selectivity is high, and obtained ursodesoxycholic acid is high in purity.

Description

The method of silyation technigue purifying ursodeoxycholic acid
Technical field
The present invention relates to medicine separation field, more specifically, relate to the separation purification method of ursodesoxycholic acid, particularly a kind of method of silyation technigue purifying ursodeoxycholic acid.
Background technology
Ursodesoxycholic acid (Ursodeoxycholic acid, UDCA, 3 α, 7 beta-dihydroxyl-5 β-cholestane-24-acid), is the main effective constituent of rare Chinese medicine bear gall, is unique medicine for the treatment of primary biliary cirrhosis (PBC).Clinical application both at home and abroad proves, ursodesoxycholic acid, at treatment various courage diseases, hepatopathy and various hyperlipidaemic conditions, is especially having good curative effect aspect dissolving cholesterol type gallbladdergallstonecholetithiasis; find again in recent years the curative effect that some are new; as cytoprotection, immunoregulation effect, antitumous effect etc.
In view of the importance of ursodesoxycholic acid, the demand of its clinical application constantly increases.But natural ursodesoxycholic acid derives from bile, the bear that kills is in the past got courage and present live body drainage, and not only source is few, and violates protection of animal principle.Therefore, synthetic ursodesoxycholic acid, and it is most important to extract highly purified ursodesoxycholic acid.(electroreduction is prepared the method for ursodesoxycholic acid to another patented product of research department, publication number CN102660755A) develop electroreduction 7-Ketolithocholsaeure (7-Ketolithocholic acid, 7K-LCA, 3 Alpha-hydroxies-7-oxygen-5 β-ursodeoxycholic acid) prepare the green synthesis method of ursodesoxycholic acid, in the electroreduction product that wherein obtained except ursodesoxycholic acid, also has raw material 7-Ketolithocholsaeure, and by product Chenodiol (Chenodeoxycholic acid, CDCA, 3 α, 7 alpha-dihydroxy--5 β-cholestane-24-acid).
At present, industrial employing organic solvent optionally dissolves away the impurity such as Chenodiol from the cholic acid mixture that contains ursodesoxycholic acid.Ethyl acetate, chloroform and ether etc. can optionally dissolve Chenodiol.But because both solubleness in above-mentioned solvent are all little, need to use a large amount of organic solvents, solvent recuperation power consumption is huge.Although the organic solvent such as ethanol, acetic acid is all larger to the solubleness of these two kinds of cholic acid, lacks selectivity, be also not suitable for industrial production.
So a kind of reagent consumption is few, selectivity is high, and the method for the purifying ursodeoxycholic acid that the ursodesoxycholic acid purity that obtains is high extremely has practical value.
Summary of the invention
Object of the present invention is exactly the problems and shortcomings for above existence, and the method for the silyation technigue purifying ursodeoxycholic acid that a kind of reagent consumption is few, selectivity is high, obtain ursodesoxycholic acid purity is high is provided.
To achieve these goals, the invention provides a kind of method of alkanisation technology purifying ursodeoxycholic acid, be characterized in, comprise the following steps:
Step 1: the mixture that contains ursodesoxycholic acid (A) is dissolved in organic solvent, adds silylating reagent to react at 25~80 DEG C, reaction formula is as follows, makes the solution that contains ursodesoxycholic acid Silylation thing (B),
Wherein, R is the alkyl that contains 1~5 carbon atom, and X is the alkyl that contains 1~6 carbon atom;
Step 2: the cooling described solution that contains ursodesoxycholic acid Silylation thing (B) at 0~5 DEG C, makes to obtain ursodesoxycholic acid Silylation thing (B) after its Crystallization Separation;
Step 3: described ursodesoxycholic acid Silylation thing (B) is added to mineral acid, stir, carry out acid hydrolysis at 40~60 DEG C, reaction formula is as follows, obtains ursodesoxycholic acid sterling (C) after separation is dry.
Preferably, the described mixture that contains ursodesoxycholic acid (A) is electroreduction 7-Ketolithocholsaeure product.The derivant structure formula that its reaction generates is as follows:
Preferably, the ursodeoxycholic acid content described in the described mixture that contains ursodesoxycholic acid (A) is 20~70wt%.Preferably, described organic solvent is aromatic hydrocarbon or chloride aliphatic category hydrocarbon.
More preferably, described aromatic hydrocarbon is at least one in benzene, toluene, nitrile, ester class, amides and their derivative;
Described chloride aliphatic category hydrocarbon is trichloromethane, methylene dichloride, tetracol phenixin, and at least one in aliphatics and aromatic ketone, as acetone, methyl iso-butyl ketone (MIBK) etc.
Preferably, described silylating reagent is that two substituted alkyl silicon halogenide, three substituted alkyl silicon halogenide, two replace silicon urea, three at least one that replace in silicon urea and dialkyl group silicon acid amides.
More preferably, no more than 5 of carbon atom in described silylating reagent alkyl.
Preferably, described mineral acid is at least one in 5% sulfuric acid, 5% hydrochloric acid and 5% phosphoric acid.
Preferably, described ursodesoxycholic acid sterling (C) purity is higher than 99.0%.
The beneficial effect of above-mentioned purification process is: on the basis that is ursodesoxycholic acid at electroreduction 7-Ketolithocholsaeure product, realize the isolation and purification of ursodesoxycholic acid, reagent consumption is few, and selectivity is high, and the ursodesoxycholic acid purity obtaining is high, can reach more than 99%.
Ursodeoxycholic acid derivative can be in organic solvent crystallization, and large polycomponent in the electroreduction 7-Ketolithocholsaeure product solubleness in organic solvent is larger, uncrystallizable separating out, thereby ursodesoxycholic acid derivatives selectively is separated efficiently.
The ursodeoxycholic acid derivative of gained, through acid hydrolysis, is sloughed to the silicon ether on molecule, regenerate ursodesoxycholic acid, after suction filtration separates, dry, just can obtain highly purified ursodesoxycholic acid.
Brief description of the drawings
Fig. 1 is the content schematic diagram of the front ursodesoxycholic acid of purifying in ursodeoxycholic acid crude in the embodiment of the present invention.
Fig. 2 is the content schematic diagram of ursodesoxycholic acid after purifying in the embodiment of the present invention.
Embodiment
In order more clearly to understand technology contents of the present invention, describe in detail especially exemplified by following examples by reference to the accompanying drawings.
Embodiment 1
Fig. 1 is the content schematic diagram of the front ursodesoxycholic acid of purifying in ursodeoxycholic acid crude in the embodiment of the present invention.As shown in Figure 1,10g is contained to 40% ursodesoxycholic acid dissolving crude product in 100ml acetonitrile, stirring and dissolving, and be warming up to 80 DEG C, add 15g hexamethyl two silicon ureas, react after two hours, be cooled to 0 DEG C, crystallization, suction filtration after 24h, and with appropriate acetonitrile flushing solid, obtain ursodesoxycholic acid Trimethylsilyl. derivative, m.p.124 DEG C; [α] D+49.4 ° (1% dioxane).
Fig. 2 is the content schematic diagram of ursodesoxycholic acid after purifying in the embodiment of the present invention.Above-mentioned ursodesoxycholic acid Trimethylsilyl. derivative adds in 100ml5% sulfuric acid, stir and be warming up to 50 DEG C, reaction 30min, be cooled to 0 DEG C, suction filtration, deionized water rinsing falls residual acid solution, collect dry, re-crystallizing in ethyl acetate, m.p.204 DEG C, [α] D+60.1 ° (1% ethanol).Obtain the ursodesoxycholic acid sterling shown in Fig. 2.
Embodiment 2
10g contains 40% ursodesoxycholic acid dissolving crude product in 100ml DMF, stirring and dissolving, and be warming up to 80 DEG C, add 20g hexamethyldisilazane, react after two hours, be cooled to 0 DEG C, crystallization, suction filtration after 24h, and rinse solid with appropriate DMF, obtain ursodesoxycholic acid Trimethylsilyl. derivative, m.p.126 DEG C; [α] D+49.3 ° (1% dioxane).
Above-mentioned ursodesoxycholic acid Trimethylsilyl. derivative adds in 100ml5% hydrochloric acid, stir and be warming up to 50 DEG C, reaction 30min, be cooled to 0 DEG C, suction filtration, deionized water rinsing falls residual acid solution, collect dry, re-crystallizing in ethyl acetate, m.p.203 DEG C, [α] D+61.0 ° of (1% ethanol) ursodesoxycholic acid sterling.
Embodiment 3
10g contains 40% ursodesoxycholic acid dissolving crude product in 100ml ethyl acetate, and stirring and dissolving, adds after 2.5g triethylamine, then adds 7.5g N, the two trimethylsilyl ethanamides of O-, react after five hours at 30 DEG C, are cooled to 0 DEG C, crystallization, suction filtration, ethyl acetate rinse, obtains Silylation thing.Subsequent step, with embodiment 1, obtains the ursodesoxycholic acid after purifying.
Embodiment 4
10g contains 40% ursodesoxycholic acid dissolving crude product in 80ml ethyl acetate, and stirring and dissolving adds after 5ml trimethylchlorosilane and 5ml hexamethyldisilazane, stirs and be warming up to 80 DEG C, react after one hour, be cooled to 0 DEG C, crystallization, suction filtration, ethyl acetate rinse, obtains Silylation thing.Use 5% phosphoric acid to be hydrolyzed, other subsequent steps, with embodiment 1, obtain the ursodesoxycholic acid after purifying.
The beneficial effect of the embodiment of the present invention is: reagent consumption is few, and selectivity is high, and the ursodesoxycholic acid purity obtaining is high, can reach more than 99%.
Ursodeoxycholic acid derivative can be in organic solvent crystallization, and the solubleness of the large polycomponent of electroreduction 7-Ketolithocholsaeure product in organic solvent is larger, uncrystallizable separating out, thereby ursodesoxycholic acid derivatives selectively is separated efficiently.
The ursodeoxycholic acid derivative of gained, through acid hydrolysis, is sloughed to the silicon ether on molecule, regenerate ursodesoxycholic acid, after suction filtration separates, dry, just can obtain highly purified ursodesoxycholic acid.
In this specification sheets, the present invention is described with reference to its specific embodiment.But, still can make various amendments and conversion obviously and not deviate from the spirit and scope of the present invention.Therefore, specification sheets is regarded in an illustrative, rather than a restrictive.

Claims (9)

1. a method for silyation technigue purifying ursodeoxycholic acid, is characterized in that, comprises the following steps:
Step 1: the mixture that contains ursodesoxycholic acid (A) is dissolved in organic solvent, adds silylating reagent to react at 25~80 DEG C, reaction formula is as follows, makes the solution that contains ursodesoxycholic acid Silylation thing (B),
Wherein, R is the alkyl that contains 1~5 carbon atom, and X is the alkyl that contains 1~6 carbon atom;
Step 2: the cooling described solution that contains ursodesoxycholic acid Silylation thing (B) at 0~5 DEG C, makes to separate and obtain ursodesoxycholic acid Silylation thing (B) after its crystallization;
Step 3: described ursodesoxycholic acid Silylation thing (B) is added to mineral acid, stir, carry out acid hydrolysis at 40~60 DEG C, reaction formula is as follows, obtains ursodesoxycholic acid sterling (C) after separation is dry.
2. the method for silyation technigue purifying ursodeoxycholic acid according to claim 1, is characterized in that, the described mixture that contains ursodesoxycholic acid (A) is electroreduction 7-Ketolithocholsaeure product.
3. the method for silyation technigue purifying ursodeoxycholic acid according to claim 1, is characterized in that, the ursodeoxycholic acid content described in the described mixture that contains ursodesoxycholic acid (A) is 20~70wt%.
4. the method for silyation technigue purifying ursodeoxycholic acid according to claim 1, is characterized in that, described organic solvent is aromatic hydrocarbon or chloride aliphatic category hydrocarbon.
5. the method for silyation technigue purifying ursodeoxycholic acid according to claim 4, is characterized in that, described aromatic hydrocarbon is at least one in benzene, toluene, nitrile, ester class, amides and their derivative;
Described chloride aliphatic category hydrocarbon is trichloromethane, methylene dichloride, tetracol phenixin, at least one in aliphatics and aromatic ketone.
6. the method for silyation technigue purifying ursodeoxycholic acid according to claim 1, it is characterized in that, described silylating reagent is that two substituted alkyl silicon halogenide, three substituted alkyl silicon halogenide, two replace silicon urea, three at least one that replace in silicon urea and dialkyl group silicon acid amides.
7. the method for silyation technigue purifying ursodeoxycholic acid according to claim 6, is characterized in that, no more than 5 of carbon atom in described silylating reagent alkyl.
8. the method for silyation technigue purifying ursodeoxycholic acid according to claim 1, is characterized in that, described mineral acid is at least one in 5% sulfuric acid, 5% hydrochloric acid and 5% phosphoric acid.
9. the method for silyation technigue purifying ursodeoxycholic acid according to claim 1, is characterized in that, described ursodesoxycholic acid sterling (C) purity is higher than 99.0%.
CN201410279478.2A 2014-06-20 2014-06-20 Method for purifying ursodesoxycholic acid by adopting silanization technology Pending CN104017043A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201711277931.6A CN107915767A (en) 2014-06-20 2014-06-20 The method of silyation technigue purifying ursodeoxycholic acid
CN201410279478.2A CN104017043A (en) 2014-06-20 2014-06-20 Method for purifying ursodesoxycholic acid by adopting silanization technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410279478.2A CN104017043A (en) 2014-06-20 2014-06-20 Method for purifying ursodesoxycholic acid by adopting silanization technology

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201711277931.6A Division CN107915767A (en) 2014-06-20 2014-06-20 The method of silyation technigue purifying ursodeoxycholic acid

Publications (1)

Publication Number Publication Date
CN104017043A true CN104017043A (en) 2014-09-03

Family

ID=51434086

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201711277931.6A Pending CN107915767A (en) 2014-06-20 2014-06-20 The method of silyation technigue purifying ursodeoxycholic acid
CN201410279478.2A Pending CN104017043A (en) 2014-06-20 2014-06-20 Method for purifying ursodesoxycholic acid by adopting silanization technology

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201711277931.6A Pending CN107915767A (en) 2014-06-20 2014-06-20 The method of silyation technigue purifying ursodeoxycholic acid

Country Status (1)

Country Link
CN (2) CN107915767A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104328454A (en) * 2014-09-29 2015-02-04 华东理工大学 Method for stereo-selectively preparing ursodesoxycholic acid
CN104804055A (en) * 2015-03-18 2015-07-29 苏州天绿生物制药有限公司 Method for purifying 7-ketolithocholic acid by adopting silylation reagent
CN106928306A (en) * 2017-03-15 2017-07-07 眉山市新功生物科技有限公司 A kind of purification process of urso
CN114892189A (en) * 2022-06-20 2022-08-12 华东理工大学 Method for generating ursodeoxycholic acid by electroreduction in composite aprotic solvent

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110003302B (en) * 2019-04-30 2021-05-11 山东省药学科学院 Refining method of 7-ketolithocholic acid

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024292A1 (en) * 1979-07-12 1981-03-04 BLASCHIM S.p.A. Process for the separation of ursodeoxycholic acid from chenodeoxycholic acid and products obtained during the process
JPS59139399A (en) * 1983-01-31 1984-08-10 Showa Denko Kk Production of ursodeoxycholic acid
JP2004307390A (en) * 2003-04-07 2004-11-04 Mitsubishi Chemicals Corp Method for producing steroid compound
CN102702294A (en) * 2010-12-09 2012-10-03 毕思宾 Purification and preparation method for direct extraction and synthesis of ursodeoxycholic acid from pig gall paste or scraps
CN102911235A (en) * 2011-08-01 2013-02-06 天津科技大学 Method for producing ursodesoxycholic acid by using chenodeoxycholic acid as raw material
CN103012532A (en) * 2012-12-10 2013-04-03 辽宁百凤生物药业有限公司 Method for producing ursodesoxycholic acid with 98.5 percent sodium cholate
CN103804453A (en) * 2013-09-30 2014-05-21 淮北市恒通生物科技有限公司 Method for preparing ursodesoxycholic acid with pig bile as raw material

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024292A1 (en) * 1979-07-12 1981-03-04 BLASCHIM S.p.A. Process for the separation of ursodeoxycholic acid from chenodeoxycholic acid and products obtained during the process
JPS59139399A (en) * 1983-01-31 1984-08-10 Showa Denko Kk Production of ursodeoxycholic acid
JP2004307390A (en) * 2003-04-07 2004-11-04 Mitsubishi Chemicals Corp Method for producing steroid compound
CN102702294A (en) * 2010-12-09 2012-10-03 毕思宾 Purification and preparation method for direct extraction and synthesis of ursodeoxycholic acid from pig gall paste or scraps
CN102911235A (en) * 2011-08-01 2013-02-06 天津科技大学 Method for producing ursodesoxycholic acid by using chenodeoxycholic acid as raw material
CN103012532A (en) * 2012-12-10 2013-04-03 辽宁百凤生物药业有限公司 Method for producing ursodesoxycholic acid with 98.5 percent sodium cholate
CN103804453A (en) * 2013-09-30 2014-05-21 淮北市恒通生物科技有限公司 Method for preparing ursodesoxycholic acid with pig bile as raw material

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TAKASHI IIDA 等: "Capillary gas chromatographic behavior of stereoisomeric bile acids with a vicinal glycol structure by their "mixed"alkylboronate derivatives", 《JOURNAL OF CHROMATOGRAPHY》, vol. 537, 31 December 1991 (1991-12-31), pages 345 - 356 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104328454A (en) * 2014-09-29 2015-02-04 华东理工大学 Method for stereo-selectively preparing ursodesoxycholic acid
CN104804055A (en) * 2015-03-18 2015-07-29 苏州天绿生物制药有限公司 Method for purifying 7-ketolithocholic acid by adopting silylation reagent
CN104804055B (en) * 2015-03-18 2016-07-06 苏州天绿生物制药有限公司 A kind of method adopting silylating reagent purification 7-Ketolithocholsaeure
CN106928306A (en) * 2017-03-15 2017-07-07 眉山市新功生物科技有限公司 A kind of purification process of urso
CN106928306B (en) * 2017-03-15 2018-04-24 眉山市新功生物科技有限公司 A kind of purification process of urso
CN114892189A (en) * 2022-06-20 2022-08-12 华东理工大学 Method for generating ursodeoxycholic acid by electroreduction in composite aprotic solvent
CN114892189B (en) * 2022-06-20 2024-01-26 华东理工大学 Method for generating ursodeoxycholic acid by electroreduction in composite aprotic solvent

Also Published As

Publication number Publication date
CN107915767A (en) 2018-04-17

Similar Documents

Publication Publication Date Title
CN104017043A (en) Method for purifying ursodesoxycholic acid by adopting silanization technology
WO2014020024A1 (en) Process for preparing high purity ursodeoxycholic acid
CN113480589B (en) Purification method of ursodeoxycholic acid
WO2015063659A1 (en) Process for the preparation of glycerol phenylbutyrate
CN108794557A (en) A kind of preparation method of chenodeoxycholic acid and intermediate
CN102206151B (en) Synthetic method of royaljelly acid
RU2014112957A (en) METHOD FOR ISOLATION OF INGENOL
CN107200765A (en) A kind of Tauro ursodesoxy cholic acid synthetic method
CN102911235A (en) Method for producing ursodesoxycholic acid by using chenodeoxycholic acid as raw material
CN103073469A (en) Preparation method for alfacalcidol
CN103601782A (en) Preparation method of prednisone acetate or analogues thereof
CN102718829A (en) Method for preparing sodium tauroursodeoxycholate
JP5955985B2 (en) New method for producing ciclesonide
CN102391128B (en) Production method of antibiotic pharmaceutical intermediate mono-p-nitro benzyl malonate
CN108997377B (en) Preparation method of E-type 7-ATCA
CN101550146A (en) Cefetamet pivoxil hydrochloride compound and preparation method thereof
CN101759740B (en) Method for synthesizing 3-alpha-acetoxy-deoxidized androstane-5-17-ketone
WO2009112557A2 (en) Process for the preparation of pregnane derivatives
CN103665078B (en) A kind of preparation method of 17 Alpha-hydroxy steroidal esters
JP5856715B2 (en) Calcium fluoride purification method
CN104804055A (en) Method for purifying 7-ketolithocholic acid by adopting silylation reagent
CN102557980A (en) Method for preparing high-purity capsaicine monomer by crystallization
CN106831809A (en) A kind of method extracted from zymotic fluid and purify mibemycin
CN104119414A (en) Preparation method of high-quality progesterone
CN103992263A (en) Donepezil purifying method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140903